Silverfin false 31/03/2023 01/04/2022 31/03/2023 Mr H Hosny 14/06/2022 Mrs R Mahfouz 29/06/2022 24 September 2023 The principal activity of the company during the financial year was that of the provision of medical services. 14171813 2023-03-31 14171813 bus:Director1 2023-03-31 14171813 bus:Director2 2023-03-31 14171813 core:CurrentFinancialInstruments 2023-03-31 14171813 core:ShareCapital 2023-03-31 14171813 core:RetainedEarningsAccumulatedLosses 2023-03-31 14171813 bus:OrdinaryShareClass1 2023-03-31 14171813 bus:OrdinaryShareClass2 2023-03-31 14171813 bus:OrdinaryShareClass3 2023-03-31 14171813 bus:OrdinaryShareClass4 2023-03-31 14171813 bus:OrdinaryShareClass5 2023-03-31 14171813 2022-04-01 2023-03-31 14171813 bus:FullAccounts 2022-04-01 2023-03-31 14171813 bus:SmallEntities 2022-04-01 2023-03-31 14171813 bus:AuditExemptWithAccountantsReport 2022-04-01 2023-03-31 14171813 bus:PrivateLimitedCompanyLtd 2022-04-01 2023-03-31 14171813 bus:Director1 2022-04-01 2023-03-31 14171813 bus:Director2 2022-04-01 2023-03-31 14171813 bus:OrdinaryShareClass1 2022-04-01 2023-03-31 14171813 bus:OrdinaryShareClass2 2022-04-01 2023-03-31 14171813 bus:OrdinaryShareClass3 2022-04-01 2023-03-31 14171813 bus:OrdinaryShareClass4 2022-04-01 2023-03-31 14171813 bus:OrdinaryShareClass5 2022-04-01 2023-03-31 iso4217:GBP xbrli:pure xbrli:shares

Company No: 14171813 (England and Wales)

HART MEDICS LTD

Unaudited Financial Statements
For the financial period ended 31 March 2023
Pages for filing with the registrar

HART MEDICS LTD

Unaudited Financial Statements

For the financial period ended 31 March 2023

Contents

HART MEDICS LTD

BALANCE SHEET

As at 31 March 2023
HART MEDICS LTD

BALANCE SHEET (continued)

As at 31 March 2023
2023
£
Current assets
Debtors 3 14,910
Cash at bank and in hand 39,443
54,353
Creditors: amounts falling due within one year 4 ( 17,945)
Net current assets 36,408
Total assets less current liabilities 36,408
Net assets 36,408
Capital and reserves
Called-up share capital 5 100
Profit and loss account 36,308
Total shareholders' funds 36,408

For the financial period ending 31 March 2023 the Company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

The financial statements of Hart Medics Ltd (registered number: 14171813) were approved and authorised for issue by the Board of Directors on 24 September 2023. They were signed on its behalf by:

Mr H Hosny
Director
HART MEDICS LTD

NOTES TO THE FINANCIAL STATEMENTS

For the financial period ended 31 March 2023
HART MEDICS LTD

NOTES TO THE FINANCIAL STATEMENTS

For the financial period ended 31 March 2023
1. Accounting policies

The principal accounting policies are summarised below. They have all been applied consistently throughout the financial period, unless otherwise stated.

General information and basis of accounting

Hart Medics Ltd (the Company) is a private company, limited by shares, incorporated in the United Kingdom under the Companies Act 2006 and is registered in England and Wales. The address of the Company's registered office is C/O Francis Clark Llp Melville Building East, Royal William Yard, Plymouth, PL1 3RP, United Kingdom.

The financial statements have been prepared under the historical cost convention, modified to include certain items at fair value, and in accordance with Section 1A of Financial Reporting Standard 102 (FRS 102) ‘The Financial Reporting Standard applicable in the UK and Republic of Ireland’ issued by the Financial Reporting Council and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime.

The financial statements are presented in pounds sterling which is the functional currency of the Company and rounded to the nearest £.

Reporting period length

The company incorporated on 14 June 2022 and started trading on 1 July 2022. It chose its first year end as 31 March 2023. As such, it has a reporting period length of 273 days.

Turnover

Turnover is stated net of VAT and trade discounts and is recognised when the significant risks and rewards are considered to have been transferred to the buyer. Revenue from services is recognised as they are delivered.

Taxation

Current tax
Current tax is provided at amounts expected to be paid (or recoverable) using the tax rates and laws that have been enacted or substantively enacted at the Balance Sheet date.

Financial instruments

Financial assets and financial liabilities are recognised when the Company becomes a party to the contractual provisions of the instrument.

Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the Company after deducting all of its liabilities.

Financial assets and liabilities are only offset in the Balance Sheet when, and only when there exists a legally enforceable right to set off the recognised amounts and the Company intends either to settle on a net basis, or to realise the asset and settle the liability simultaneously.

Basic financial assets
Basic financial assets receivable within one year, such as trade debtors and bank balances, are measured at transaction price less any impairment.

Basic financial assets receivable within more than one year are measured at amortised cost less any impairment.

Financial assets are derecognised when and only when the contractual rights to the cash flows from the financial asset expire or are settled, or the Company transfers to another party substantially all of the risks and rewards of ownership of the financial asset, or the Company, despite having retained some, but not all, significant risks and rewards of ownership, has transferred control of the asset to another party.

Basic financial liabilities
Basic financial liabilities that have no stated interest rate and are payable within one year, such as trade creditors, are measured at transaction price.

Other basic financial liabilities are measured at amortised cost.

Financial liabilities are derecognised when the company’s contractual obligations expire or are discharged or cancelled.

2. Employees

2023
Number
Monthly average number of persons employed by the Company during the period, including directors 0

3. Debtors

2023
£
Trade debtors 14,910

4. Creditors: amounts falling due within one year

2023
£
Taxation and social security 15,564
Other creditors 2,381
17,945

5. Called-up share capital

2023
£
Allotted, called-up and fully-paid
4 Ordinary A shares of £ 1.00 each 4
48 Ordinary B shares of £ 1.00 each 48
16 Ordinary C shares of £ 1.00 each 16
16 Ordinary D shares of £ 1.00 each 16
16 Ordinary E shares of £ 1.00 each 16
100

The above shares were issued during the financial period.